Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fortis Healthcare Limited (FORTIS.NS)
INR976.15
+6.40 (+0.66%)
IN NSE Healthcare Medical - Care Facilities
Address
Tower A 122001
Gurugram, IN
Gurugram, IN
CEO
Ashutosh Raghuvanshi
Website
fortishealthcare.com
IPO
2007-05-09
ISIN INE061F01013
Also trades on
Bombay Stock Exchange · FORTIS.BO (INR)
National Stock Exchange of India · FORTIS.NS (INR)
Description
Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare Limited operates as an integrated provider of healthcare services. The company extends its offerings, which encompass secondary, tertiary, and quaternary medical care, across India, the United Arab Emirates, Sri Lanka, and other international markets. Its diverse healthcare infrastructure includes a network of hospitals, diagnostic facilities, and specialized day-care centers. Fortis delivers expertise across a broad spectrum of medical disciplines, including cardiology, cosmetic and dental sciences, dermatology, endocrinology, emergency medicine, ENT, fetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatment, internal medicine, mental and behavioral health, nephrology, neurosurgery, neurointervention, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy, plastic surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplant medicine, urology, and numerous other supporting specialties. By March 31, 2022, the company managed 26 hospitals, housing approximately 4,300 operational beds, in addition to around 426 diagnostic centers and laboratories, complemented by 2,550 collection centers.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR976.15
+6.40 (+0.66%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.65
Float Shares
489.31M
Free Float %
64.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.39% | -1.46% | +4.01% | +0.31% | +3.61% | +9.34% | +36.49% | +236.44% | +325.35% | +458.24% | +865.15% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
976.15
DCF (Unlevered)
194.30
-80.1%
DCF (Levered)
299.95
-69.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
83% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 13 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
8.45
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+17.2% ★ Q1'26: +17.8% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+34.5% ★ Q1'26: +44.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+9.0% Q1'26: +3.4% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+17.9% ★ Q1'26: +17.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+9.7% ★ Q1'26: +12.9% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.12× Q1'26: 0.65× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2009 actual |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 18 Rev. Ana. 14 EPS Ana. |
Mar 2027 18 Rev. Ana. 15 EPS Ana. |
Mar 2028 16 Rev. Ana. 14 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.31B
est: 6.35B (-0.7%)
|
9.38B
est: 9.27B (+1.2%)
|
14.83B
est: 15.50B (-4.3%)
|
29.84B
est: 23.68B (+26.0%)
|
30.42B
est: 59.35B (-48.7%)
|
34.92B
est: 47.43B (-26.4%)
|
39.66B
est: 41.67B (-4.8%)
|
41.99B
est: 43.65B (-3.8%)
|
45.74B
est: 46.18B (-1.0%)
|
45.61B
est: 46.36B (-1.6%)
|
44.69B
est: 42.62B (+4.9%)
|
46.32B
est: 46.72B (-0.9%)
|
40.30B
est: 39.80B (+1.3%)
|
57.18B
est: 57.88B (-1.2%)
|
62.98B
est: 62.93B (+0.1%)
|
68.97B
est: 70.94B (-2.8%)
|
77.86B
est: 78.18B (-0.4%)
|
91.35B
89.85B – 94.20B
+16.8% YoY
|
107.24B
103.46B – 113.63B
+17.4% YoY
|
123.74B
116.50B – 136.66B
+15.4% YoY
|
| EBITDA |
1.14B
est: -546.19M (+309.2%)
|
1.91B
est: 751.67M (+153.6%)
|
970.41M
est: 1.92B (-49.5%)
|
5.47B
est: 5.99B (-8.6%)
|
2.28B
est: 4.62B (-50.6%)
|
891.93M
est: 13.06B (-93.2%)
|
1.36B
est: 2.04B (-33.6%)
|
1.74B
est: 349.73M (+398.0%)
|
3.22B
est: 3.51B (-8.4%)
|
3.22B
est: 11.67B (-72.4%)
|
2.30B
est: -8.09B (+128.4%)
|
5.33B
est: 2.09B (+155.3%)
|
3.47B
est: 2.49B (+39.6%)
|
9.96B
est: 3.48B (+186.2%)
|
10.37B
est: 3.78B (+174.7%)
|
11.87B
est: 12.52B (-5.2%)
|
15.00B
est: 13.85B (+8.3%)
|
16.13B
15.86B – 16.63B
+16.4% YoY
|
18.93B
18.26B – 20.06B
+17.4% YoY
|
21.84B
20.57B – 24.12B
+15.4% YoY
|
| EBIT |
655.13M
est: -322.02M (+303.4%)
|
1.31B
est: 623.23M (+109.7%)
|
3.07B
est: 1.42B (+115.5%)
|
3.05B
est: -291.21M (+1,146.7%)
|
243.44M
est: 5.64B (-95.7%)
|
-936.47M
est: 327.63M (-385.8%)
|
-948.10M
est: -1.27B (+25.5%)
|
-232.99M
est: -1.07B (+78.1%)
|
1.32B
est: -622.47M (+311.8%)
|
1.23B
est: 1.34B (-8.3%)
|
333.12M
est: -7.90B (+104.2%)
|
3.11B
est: -2.20B (+241.1%)
|
1.18B
est: 3.10B (-61.9%)
|
7.60B
est: 4.34B (+75.0%)
|
7.84B
est: 4.72B (+66.4%)
|
9.19B
est: 10.26B (-10.4%)
|
11.95B
est: 11.35B (+5.3%)
|
13.22B
13.00B – 13.63B
+16.4% YoY
|
15.52B
14.97B – 16.44B
+17.4% YoY
|
17.90B
16.86B – 19.77B
+15.4% YoY
|
| Net Income |
208.19M
est: -688.62M (+130.2%)
|
694.81M
est: 305.05M (+127.8%)
|
1.24B
est: 1.18B (+5.3%)
|
722.22M
est: 1.85B (-61.0%)
|
4.85B
est: 1.81B (+168.0%)
|
1.23B
est: 4.03B (-69.6%)
|
-1.44B
est: 1.09B (-231.8%)
|
184.24M
est: -1.53B (+112.0%)
|
4.22B
est: 193.97M (+2,073.8%)
|
-10.09B
est: 4.29B (-335.4%)
|
-2.99B
est: -9.83B (+69.6%)
|
579.36M
est: -3.03B (+119.1%)
|
-1.10B
est: 472.76M (-332.2%)
|
5.55B
est: 661.59M (+739.1%)
|
5.89B
est: 5.78B (+1.8%)
|
5.99B
est: 6.53B (-8.3%)
|
7.74B
est: 8.69B (-10.9%)
|
10.42B
10.07B – 11.97B
+19.9% YoY
|
14.33B
13.13B – 15.25B
+37.6% YoY
|
18.26B
16.08B – 20.67B
+27.4% YoY
|
| SGA |
644.92M
est: 2.51B (-74.3%)
|
976.53M
est: 3.54B (-72.4%)
|
3.20B
est: 6.24B (-48.7%)
|
8.49B
est: 10.91B (-22.2%)
|
4.20B
est: 25.81B (-83.7%)
|
4.86B
est: 11.36B (-57.2%)
|
970.86M
est: 22.06B (-95.6%)
|
997.66M
est: 28.93B (-96.6%)
|
901.45M
est: 30.05B (-97.0%)
|
2.76B
est: 30.73B (-91.0%)
|
2.87B
est: 29.94B (-90.4%)
|
2.45B
est: 31.47B (-92.2%)
|
1.32B
est: 23.19B (-94.3%)
|
2.30B
est: 32.45B (-92.9%)
|
3.08B
est: 35.22B (-91.2%)
|
3.42B
est: 5.38B (-36.5%)
|
4.15B
est: 52.81B (-92.1%)
|
6.93B
6.81B – 7.14B
-86.9% YoY
|
8.13B
7.85B – 8.62B
+17.4% YoY
|
9.38B
8.84B – 10.36B
+15.4% YoY
|
| EPS |
0.64
est: 0.46 (+40.7%)
|
2.62
est: 2.02 (+29.9%)
|
3.23
est: 3.23 (0.0%)
|
1.78
est: 1.80 (-1.0%)
|
12.34
est: -1.42 (+967.6%)
|
2.70
est: -1.40 (+293.3%)
|
-2.23
est: -2.37 (+6.0%)
|
-0.39
est: 1.19 (-132.8%)
|
8.87
est: 1.73 (+412.1%)
|
-15.67
est: -0.34 (-4,577.5%)
|
-4.64
est: -3.99 (-16.4%)
|
0.77
est: 1.70 (-54.8%)
|
-1.45
est: -1.02 (-42.5%)
|
7.35
est: 4.94 (+48.8%)
|
7.80
est: 7.03 (+11.0%)
|
7.93
est: 8.65 (-8.4%)
|
10.26
est: 11.06 (-7.2%)
|
14.10
13.34 – 15.85
+27.5% YoY
|
18.92
17.40 – 20.20
+34.2% YoY
|
24.21
21.30 – 27.39
+27.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
11.11B
OE per share TTM
14.72
Owner's Yield
1.52%
Maintenance CapEx ratio
89.29%
Maint CapEx / Avg PPE
89.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 18 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Schwab Emerging Markets Equity ETF SCHE | 0.05% | 6.01M | 0.06% |
| 2 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.05% | 2.63M | 0.17% |
| 3 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.05% | 2.63M | 0.17% |
| 4 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.04% | 571.6K | 0.48% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.04% | 1.29M | 0.26% |
| 6 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.04% | 225.4K | 0.40% |
| 7 | Vanguard All-World ex-US Shares Index ETF VEU.AX | 0.01% | 511.3K | 0.04% |
| 8 | Vanguard FTSE All-World UCITS ETF (USD) Distributing VWRD.L | 0.01% | 5.71M | 0.19% |
| 9 | Vanguard FTSE All-World UCITS ETF (USD) Accumulating VWRA.L | 0.01% | 5.71M | 0.19% |
| 10 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 102.2K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.35M
Shares Outstanding
754.96M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ashutosh Raghuvanshi | MD, Chief Executive Officer & Director | 96M | — |
| Satyendra Chauhan | Company Secretary & Compliance Officer | 2M | male |
| Anurag Kalra | Vice President of Investor Relations | — | male |
| Bipin Kumar | Chief Information Officer | — | male |
| Daljit Singh | President | — | male |
| Prabhat Kumar | Group General Counsel | — | male |
| Ranjan Pandey | Chief Human Resources Officer | — | male |
| Ajey Maharaj | Head of Corporate Communication & PR and Corporate Administration | — | male |
| Vivek Kumar Goyal | Chief Financial Officer | — | male |
| Anil Vinayak | Group Chief Operating Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FORTIS.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
